Janus Kinase 3 (JAK3) Aberrations in Non-Small Cell Lung Cancer

被引：0
作者：
Toth, Laura N.
Amos, Christopher I.
Dragnev, Konstantin H.
Tsongalis, Gregory J.
Tafe, Laura J.
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Norris Cotton Canc Ctr, Lebanon, NH USA
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1928
引用
收藏
页码：485A / 485A
页数：1
相关论文
共 50 条
  • [21] Gene Expression and Functional Studies of Janus Kinase 3 (JAK3) in Ovarian Granulosa Cells
    Ndiaye, Kalidou
    Silversides, David
    Lussier, Jacques
    FASEB JOURNAL, 2015, 29
  • [22] Structure based design of immunomodulator agents which inhibit Janus Kinase 3 (JAK3).
    Sudbeck, EA
    Liu, XP
    Mahajan, S
    Narla, RK
    Mao, C
    Uckun, FM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S119 - S119
  • [23] Class IA Phosphatidylinositol 3-Kinase Signaling in Non-small Cell Lung Cancer
    Solomon, Benjamin
    Pearson, Richard B.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (07) : 787 - 791
  • [24] Landscape of FGFRactivating aberrations in Chinese non-small cell lung cancer
    Zhou, Zhen
    Liu, Zichuan
    Ou, Qiuxiang
    Wu, Xue
    Wang, Xiaonan
    Shao, Yang
    Liu, Hongyan
    Yang, Yu
    CANCER RESEARCH, 2020, 80 (16)
  • [25] Activation of Janus kinase 1 confers poor prognosis in patients with non-small cell lung cancer
    Liu, Dan
    Huang, Yi
    Zhang, Li
    Liang, Dong-Ni
    Li, Li
    ONCOLOGY LETTERS, 2017, 14 (04) : 3959 - 3966
  • [26] JAK3: not just another kinase
    Friedrich, W
    BLOOD, 2004, 103 (06) : 1978 - 1979
  • [27] The specificity of JAK3 kinase inhibitors
    Changelian, Paul S.
    Moshinsky, Deborah
    Kuhn, Cyrille F.
    Flanagan, Mark E.
    Munchhof, Michael J.
    Harris, Thomas M.
    Doty, Jonathan L.
    Sun, Jianmin
    Kent, Craig R.
    Magnuson, Kelly S.
    Perregaux, David G.
    Sawyer, Perry S.
    Kudlacz, Elizabeth M.
    BLOOD, 2008, 111 (04) : 2155 - 2157
  • [28] Identification of MAP Kinase Kinase 3 as a protein target of myricetin in non-small cell lung cancer cells
    Gu, Ling
    Li, Zhihui
    Zhang, Xiongfei
    Chen, Meijuan
    Zhang, Xu
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [29] The transcription factor Ets-1 is essential for janus kinase 3 (Jak3) promoter activity
    Aringer, M
    Hofmann, S
    Frucht, DM
    Min, C
    Centola, M
    Morinobu, A
    Visconti, R
    Haleem-Smith, H
    Kastner, DL
    Smolen, JS
    O'Shea, JJ
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S346 - S346
  • [30] Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation
    Roberts, JL
    Lengi, A
    Brown, SM
    Chen, M
    Zhou, YJ
    O'Shea, JJ
    Buckley, RH
    BLOOD, 2004, 103 (06) : 2009 - 2018
12345